Novo’s Wegovy pill could be a game-changer
Digest more
Eli Lilly (LLY) has shown considerable rally potential, with several occurrences of its stock climbing over 30% in less than ...
Eli Lilly and Company (NYSE:LLY) is one of the Best Stocks to Invest in for the Next 3 Years. On December 12, Eli Lilly and ...
Eli Lilly is investing $6B in a Huntsville, Ala., plant to make weight-loss and other medicines. Here’s what we know about ...
Eli Lilly's shares may appear expensive at first glance, but a closer look reveals a different story. The company's outlook ...
Eli Lilly and Company (NYSE: LLY) is one of the stocks Jim Cramer answered questions about. Inquiring if their portfolio is ...
Healthcare giant Eli Lilly is now the first global healthcare company to hit $1 trillion in value riding on the popularity of ...
In an added benefit, more than one in eight people taking the highest dose of Retratrutide were completely free of arthritic ...
Lilly has already submitted the combination data for US regulatory review in ESR1-mutated metastatic breast cancer.
Eli Lilly hiked its revenue growth guidance by 7%, while Novo Nordisk was forced to slash its targets by ~12%. See why I'm still bullish on LLY stock.
Eli Lilly to invest $6 billion in new synthetic medicine facility in Huntsville, AL to boost domestic production and create 450 jobs.
Global pharmaceutical leaders Eli Lilly and Novo Nordisk are intensifying competition in Indias rapidly expanding obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback